ื”ืขืœืืช ื”ืžื•ื“ืขื•ืช ืฉืœ CMV ืžื•ืœื“ืช ื‘ืื•ืกื˜ืจืœื™ื”

ืชื•ื›ืŸ:

{title} ื”ืกื™ืคื•ืจ ืฉืœ ืืžืžืœื™ืŸ ื•ื•ื™ืœื™ืื: CMV ืžืžื™ืœื

ืืžื ืฉืœ ืกื™ื“ื ื™ ืœืืจื‘ืขื” ืคื•ืขืœืช ืœื”ืขืœืืช ื”ืžื•ื“ืขื•ืช ื‘ืขื•ืœื ืฉืœ ื•ื™ืจื•ืก ื ืคื•ืฅ ืฉื™ื›ื•ืœ ืœื’ืจื•ื ืœืžื•ืžื™ื ืžื•ืœื“ื™ื ื•ื ื›ื•ื™ื•ืช ื”ืชืคืชื—ื•ืชื™ื•ืช .

ืงื™ื™ื˜ ื“ืืœื™, ืื ืœืืจื‘ืขื” ื™ืœื“ื™ื, ื›ื•ืœืœ ืงื‘ื•ืฆื” ืฉืœ ืชืื•ืžื™ื ืฉื ื•ืœื“ื• ืขื ืฆื™ื˜ื•ืžื’ืœื•ื•ื™ืจื•ืก ืžื•ืœื“ (CMV) ื‘ -2010, ืจื•ืฆื” ืœืขื–ื•ืจ ื‘ื—ื™ื ื•ืš ื ืฉื™ื ื‘ื”ืจื™ื•ืŸ ื•ื‘ืจื•ืคืื™ื ืขืœ ื”ืกื›ื ื•ืช ืฉืœ CMV ื•ื›ื™ืฆื“ ื”ื ื™ื›ื•ืœื™ื ืœืžื–ืขืจ ืืช ื”ื—ืฉื™ืคื” ืฉืœื”ื ื‘ืžื”ืœืš ื”ื”ืจื™ื•ืŸ ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืืžื ื•ืชื™ื ื•ืง ื‘ืจื™ื.

"ืื—ืจื™ ื”ื‘ืŸ ืฉืœื™, ื•ื™ืœื™ืื ืื•ื‘ื—ืŸ ื‘ื’ื™ืœ 3 ืฉื‘ื•ืขื•ืช ืขื ืื™ื‘ื•ื“ ืฉืžื™ืขื” ืงื‘ื•ืข ืฉื ื’ืจื ืขืœ ื™ื“ื™ CMV ื”ื™ื™ืชื™ ื”ืžื•ื ืœื’ืœื•ืช ืฉื™ืฉ ืžืฉื”ื• ืฉืื ื™ ื™ื›ื•ืœ ืœืขืฉื•ืช ื›ื“ื™ ืœื ืกื•ืช ืœืžื ื•ืข ืืช ื–ื” & ืœื ื ืืžืจ ืœื™", ืื•ืžืจ ื“ืืœื™ . "ืื ื™ ืจื•ืฆื” ืœืจืื•ืช ื ืฉื™ื ื‘ื”ืจื™ื•ืŸ ืœืงื‘ืœ ืžื™ื“ืข ืขืœ CMV ื•ื™ื™ืขืฅ ืœืชืจื’ืœ ื”ื™ื’ื™ื™ื ื” ื‘ืกื™ืกื™ืช ืื ื–ื” ื™ื›ื•ืœ ืœืขื–ื•ืจ ืœืฉืžื•ืจ ืขืœ ืชื™ื ื•ืงื•ืช ื—ื™ื™ื ื•ื‘ืจื™ืื™ื." ื“ืืœื™ ื ื“ื‘ืง ื‘ื•ื•ื™ืจื•ืก ื‘ื–ืžืŸ ื”ื”ืจื™ื•ืŸ ืขื ื”ืชืื•ืžื™ื ืฉืœื”, ื•ื™ืœื™ืื Emmaline ืฉื”ื ื›ืขืช 12 ื—ื•ื“ืฉื™ื. ื‘ืขื•ื“ Emaline ืขื“ ื›ื” ื”ื™ื” ื‘ืจ ืžื–ืœ ืขื ื”ื ื’ื™ืฃ ืจืง ื ืจืื” ืœื’ืจื•ื ืœื” ืขื™ื›ื•ื‘ ื”ืชืคืชื—ื•ืชื™ ืงืœื” ื•ื™ืœื™ืื ื”ื•ืฉืคืข ื‘ืื•ืคืŸ ืžืฉืžืขื•ืชื™ ื™ื•ืชืจ ืขื ืขื™ื›ื•ื‘ ื”ืชืคืชื—ื•ืชื™ ื”ืจื‘ื” ื™ื•ืชืจ ืžืฉืžืขื•ืชื™ ื‘ืขื•ืœื ื—ื™ืจืฉื•ืช ืขืžื•ืงื”.

ื‘ 8 ื“ืฆืžื‘ืจ 2011 ื•ื™ืœื™ืื ืฆืคื•ื™ ืœืขื‘ื•ืจ ื ื™ืชื•ื— ืœื”ื™ื•ืช ืžื•ืฉืชืœื™ื ืขื ืฉืชืœื™ื ืฉื‘ืœื•ืœื™ื™ื. ืืžื• ืžืฆืคื” ืœืžืชื ืช ื—ื’ ื”ืžื•ืœื“ ื”ื˜ื•ื‘ื” ื‘ื™ื•ืชืจ ืฉื”ื™ื ื™ื›ืœื” ืœื—ืœื•ื ืขืœื™ื”, ืขื ื”ื•ืคืขืชื• ืฉืœ ืกื™-ืื™ ืฉืœ ื•ื™ืœื™ืื ื‘ื“ื™ื•ืง ื‘ื–ืžืŸ ืœืฉืžื•ืข ืืช ื”ืžื–ืžื•ืจื™ ื‘ื—ื’ ื”ืžื•ืœื“. ื“ืืœื™ ืคื•ืขืœืช ืœื”ืงืžืช ืืจื’ื•ืŸ ืœืœื ื›ื•ื•ื ืช ืจื•ื•ื—, ืืจื’ื•ืŸ ื”- CMV ื”ืขื•ืœืžื™ (CCMV World).

ืžื—ืงืจ ืฉื ืขืจืš ื‘ืฉื ืช 2010 ื‘ืืžืฆืขื•ืช ื”ื™ื—ื™ื“ื” ืœืžืขืงื‘ ื™ืœื“ื™ื ืขื•ืœืžื™ (APSU) ื“ื™ื•ื•ื— ื›ื™ ืื—ื“ ืžื›ืœ 160 ื™ืœื“ื™ื ื ื•ืœื“ ืขื CMV ืžื•ืœื“. CMV ื”ื•ื ื”ื“ืœืงืช ื”ืžื•ืœื“ืช ื”ื ืคื•ืฆื” ื‘ื™ื•ืชืจ (ื›ืœื•ืžืจ, ื‘ื”ื•ื•ื”), ื•ื”ื™ื ื”ื’ื•ืจื ื”ื ืคื•ืฅ ื‘ื™ื•ืชืจ ืœืžื•ืžื™ื ืžื•ืœื“ื™ื, ื›ื•ืœืœ ื—ื™ืจืฉื•ืช, ืขื™ื•ื•ืจื•ืŸ, ืฉื™ืชื•ืง ืžื•ื—ื™ืŸ, ื ื›ื•ื™ื•ืช ื ืคืฉื™ื•ืช ื•ื’ื•ืคื ื™ื•ืช, ื”ืชืงืคื™ื ื•ืžื•ื•ืช. ื‘ื›ืœ ืฉื ื” ื‘ืขื•ืœื, ื›ืžืขื˜ 1, 800 ื™ืœื“ื™ื ื ื•ืœื“ื™ื ืขื CMV. "ื™ื•ืชืจ ืชื™ื ื•ืงื•ืช ื ื•ืœื“ื™ื ืขื CMV ืžื•ืœื“ืชื™ ืžื›ืœ ื–ื™ื”ื•ื ืื—ืจ ื‘ื”ืจื™ื•ืŸ ื‘ืขื•ืœื", ืื•ืžืจ ืคืจื•ืค 'ื•ื•ื™ืœื™ืื ืจื•ื•ืœื™ื ืกื•ืŸ, ื•ื™ืจื•ืœื•ื’ ื‘ื›ื™ืจ ืจืคื•ืื™ ื‘ SEALS ื•ื™ืจื•ืœื•ื’ื™ื” ื‘ื‘ื™ืช ื”ื—ื•ืœื™ื ื”ื ืกื™ืš ืžื•ื•ื™ื™ืœืก. "ืื ื—ื ื• ืฆืจื™ื›ื™ื ื”ื›ืจื” ื’ื“ื•ืœื” ื™ื•ืชืจ ืฉืœ ื”ื‘ืขื™ื•ืช ื”ืงืฉื•ืจื•ืช cytomegalovirus ืื ืื ื—ื ื• ื”ื•ืœื›ื™ื ืœืขืฉื•ืช ื›ืœ ื”ืชืงื“ืžื•ืช."

ื”ืงืจื ื” ืขื‘ื•ืจ ื–ื™ื”ื•ื CMV ืืฆืœ ื ืฉื™ื ื”ืจื•ืช ื•ืชื™ื ื•ืงื•ืช ื—ื“ืฉื™ื ืื™ื ื” ืฉื’ืจืชื™ืช ื•ืชื™ื ื•ืงื•ืช ืจื‘ื™ื ืืฉืจ ืื™ื ื ืžืื•ื‘ื—ื ื™ื ื‘ื ื’ื™ืฃ ืขืœื•ืœื™ื ืœื”ืžืฉื™ืš ืœืคืชื— ืื™ื‘ื•ื“ ืฉืžื™ืขื” ื•ื ื›ื•ื™ื•ืช ื”ืชืคืชื—ื•ืชื™ื•ืช. ืื ืฉื™ ืžืงืฆื•ืข ืžืžืœื™ืฆื™ื ืขืœ ื™ื™ืขื•ืฅ ื‘ืกื™ืกื™ ืœื—ื•ืœื” ื‘ื ื•ื’ืข ืœืืžืฆืขื™ ืžื ื™ืขื” ื›ื“ื™ ืœื”ืชื’ื•ื ืŸ ืžืคื ื™ ื–ื™ื”ื•ื CMV ื‘ืžื”ืœืš ื”ื”ืจื™ื•ืŸ, ื›ื•ืœืœ ืฉื˜ื™ืคื•ืช ื™ื“ื™ื™ื ืชื›ื•ืคื•ืช, ืœื ื ืฉื™ืงื•ืช ืฉืœ ื™ืœื“ื™ื ืฆืขื™ืจื™ื ื‘ืคื” ื•ืœื ืฉื™ืชื•ืฃ ืžื–ื•ืŸ, ืžื’ื‘ื•ืช ืื• ื›ืœื™ื. "ืื ื—ื ื• ื™ื•ื“ืขื™ื ืžืžื—ืงืจื™ื ืงื•ื“ืžื™ื ืฉื›ืืฉืจ ื ืฉื™ื ื‘ื”ืจื™ื•ืŸ ืžื‘ื™ื ื•ืช ืฉื”ืŸ ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืœื–ื™ื”ื•ื, ื”ืŸ ืžืฉื ื•ืช ืืช ื”ืชื ื”ื’ื•ืชืŸ ื•ืžืคื—ื™ืชื™ื ืืช ื”ืกื™ื›ื•ืŸ ืฉืœื”ืŸ ืœืจื›ื™ืฉื” ื‘ื›ืžื—ืฆื™ืช", ืื•ืžืจ ืจื•ืœื™ื ืกื•ืŸ.

CMV ื”ื•ื ื•ื™ืจื•ืก ื ืคื•ืฅ, ืงื™ื™ื ื‘ืจื•ืง, ืฉืชืŸ, ื“ืžืขื•ืช, ื“ื, ืจื™ืจ, ื•ื”ื•ื ื ื™ืฉื ืขืœ ื™ื“ื™ ืชื™ื ื•ืงื•ืช ื‘ืจื™ืื™ื, ืคืขื•ื˜ื•ืช, ื™ืœื“ื™ื ื‘ื’ื™ืœ ื”ื’ืŸ, ื•ื™ืœื“ื™ื ืืฉืจ ื”ื—ื•ื–ื” ืืช ื”ื ื’ื™ืฃ ืžืŸ ื”ืขืžื™ืชื™ื ืฉืœื”ื. ื› -60% ืžื”ื ืฉื™ื ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืœื—ืœื•ืช ื‘- CMV ื‘ืžื”ืœืš ื”ื”ืจื™ื•ืŸ, ืžื”ื•ื•ืช ืกื™ื›ื•ืŸ ืžืฉืžืขื•ืชื™ ืœืืžื”ื•ืช, ืžืขื•ื ื•ืช ื™ื•ื ื•ื’ื ื ื•ืช. ืœืžืจื•ืช ืฉื”ื•ื•ื™ืจื•ืก ืื™ื ื• ืžื–ื™ืง ืœืจื•ื‘ ื”ืื ืฉื™ื ื”ื ื•ืฉืื™ื ืื•ืชื•, ื ืฉื™ื ื”ืจื•ืช ื”ื—ื•ืœื•ืช ื‘- CMV ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืœื”ืขื‘ืจืชืŸ ืœืชื™ื ื•ืง ื”ืžืชืคืชื— ืฉืœื”ืŸ, ืืฉืจ ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืœื–ื™ื”ื•ื ื•ื ื›ื•ืช ืœืื—ืจ ืžื›ืŸ. "ื ืฉื™ื ืื™ื ืŸ ืžื•ื“ืขื•ืช ื‘ืžื™ื“ื” ืจื‘ื” ืœ- CMV ืขื“ ืฉื™ืœื“ื ื ื•ืœื“ ืขื CMV ืžื•ืœื“. ืื ื—ื ื• ืฆืจื™ื›ื™ื ืœื˜ืคืœ ื‘ื–ื” ", ืื•ืžืจืช ืฉืจื™ืœ ื’'ื•ื ืก, ืžื•ืžื—ื™ืช ืœืžื—ืœื•ืช ื–ื™ื”ื•ืžื™ื•ืช ื‘ื™ืœื“ื™ื ื‘ื‘ื™ืช ื”ื—ื•ืœื™ื ืœื™ืœื“ื™ื ื•ืคืจื•ืค 'ืœืจืคื•ืืช ื™ืœื“ื™ื ื‘ืื•ื ื™ื‘ืจืกื™ื˜ืช ืกื™ื“ื ื™.

ืœืžืืžืจ ื”ืงื•ื“ื ืœืžืืžืจ ื”ื‘ื

ื”ืžืœืฆื•ืช ืขื‘ื•ืจ Moms.โ€ผ